<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-5256</journal-id>
<journal-title><![CDATA[Revista Med]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Med]]></abbrev-journal-title>
<issn>0121-5256</issn>
<publisher>
<publisher-name><![CDATA[Universidad Militar Nueva Granada. Facultad de Medicina]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-52562018000100064</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[LIPOHIPERTROFIA: CONOCIMIENTO Y EDUCACIÓN AL TRATAMIENTO CON INSULINA EN LA DIABETES MELLITUS]]></article-title>
<article-title xml:lang="en"><![CDATA[LIPOHYPERTROPHY: KNOWLEDGE AND EDUCATION TO TREATMENT WITH INSULIN IN DIABETES MELLITUS]]></article-title>
<article-title xml:lang="pt"><![CDATA[LIPOHIPERTROFIA: CONHECIMENTO E EDUCAÇÃO AO TRATAMENTO COM INSULINA NA DIABETE MELLITUS]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[CANO IBARRA]]></surname>
<given-names><![CDATA[SANDRA MILENA]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[LASTRE AMELL]]></surname>
<given-names><![CDATA[GLORIA]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[ORÓSTEGUI SANTANDER]]></surname>
<given-names><![CDATA[MARÍA ALEJANDRA]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Simón Bolívar  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Simón Bolívar  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad Simón Bolívar  ]]></institution>
<addr-line><![CDATA[Barranquilla ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2018</year>
</pub-date>
<volume>26</volume>
<numero>1</numero>
<fpage>64</fpage>
<lpage>71</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-52562018000100064&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-52562018000100064&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-52562018000100064&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: La diabetes mellitus tipo 1 es una enfermedad crónica que, una vez diagnosticada, genera cambios en el estilo de vida del paciente. Para lograr un tratamiento óptimo y evitar complicaciones posteriores, como lipohipertrofia por el aumento en el uso de la insulina, es de vital importancia que se brinde a los pacientes y el personal médico una adecuada educación, para que adquieran conocimientos y habilidades en la aplicación de la inyección de insulina. La lipohipertrofia se presenta por acumulación de grasa subcutánea en el sitio donde se inyecta constantemente la insulina.  Objetivo: Describir la lipohipertrofia en pacientes con diabetes mellitus, los conocimientos y educación que debe adquirir con respecto al tema.  Metodología: Se realizó una revisión de literatura en las bases de datos SciELO, Ovid, Medline, PubMed, ScienceDirect y Elsevier, que permitió identificar 71 artículos, de los cuales 50 cumplían con los criterios y pertinencia de la búsqueda.  Resultados: Se seleccionó la información más completa y pertinente de las bases de datos, respecto a la lipohipertrofia, conocimiento, educación y tratamiento con insulina en la diabetes Mellitus.  Conclusión: Esta revisión permitió determinar que la lipohipertrofia, una complicación secundaria del tratamiento con insulina en la diabetes Mellitus; se origina en factores tales como la técnica de aplicación y rotación inadecuadas de los puntos de inyección, el escaso conocimiento de los pacientes acerca del tratamiento y la falta de educación del personal sanitario con respecto al uso de las técnicas de aplicación de la insulina.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Summary  Introduction: Diabetes mellitus type 1 is a chronic disease that, once diagnosed, generates changes in the patient's lifestyle. In order to achieve optimal treatment and avoid subsequent complications, such as lipohypertrophy caused by the increase in the use of insulin, it is vital that patients and medical personnel receive adequate education, so that they acquire knowledge and skills related to the application of the insulin injection. Lipohypertrophy occurs due to the accumulation of subcutaneous fat at the site where insulin is repeatedly injected.  Objective:  To describe lipohy pertrophy in patients with diabetes mellitus, as well as the knowledge and education that should be acquired on the subject.  Methodology:  A review of the literature in the databases SciELO, Ovid, Medline, PubMed, ScienceDirect, and Elsevier was carried out, from which 71 articles we identified, and of which 50 met the criteria and were relevant to the search.  Results:  The most complete and pertinent information was selected from the databases regarding lipohypertrophy, knowledge, education, and insulin treatment in diabetes mellitus.  Conclusion: This research allowed us to determine that lipohypertrophy, a secondary complication of insulin treatment in diabetes mellitus, is caused by factors such as an inadequate application technique and inadequate rotation of the injection sites, as well as the lack of knowledge that patients have regarding the treatment, and the lack of education of health personnel when it comes to the use of insulin application techniques.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução. A diabetes mellitus tipo 1 é uma doença crônica que, uma vez diagnosticada, gera mudanças no estilo de vida do paciente. Para obter um tratamento ótimo e evitar complicaçöes posteriores, como lipohipertrofia pelo aumento no uso da insulina, é de vital importância proporcionar aos pacientes e o pessoal médico uma adequada educação, para que adquiram conhecimentos e habilidades na aplicação da injeção de insulina. A lipohipertrofia se apresenta por acumulação de gordura subcutânea no lugar onde se injeta constantemente a insulina.  Objetivo: Descrever a lipohipertrofia em pacientes com diabetes mellitus, os conhecimentos e educação que deve adquirir com respeito ao tema.  Metodologia:  Se realizou una revisão de literatura nas bases de dados SciELO, Ovid, Medline, PubMed, ScienceDirect, Elsevier, que permitiu identificar 71 artigos, dos quais 50 cumpriam com os critérios e pertinência da busca.  Resultados: Selecionou-se a informação mais completa e pertinente das bases de dados, com relação à lipohipertrofia, conhecimento, educação e tratamento com insulina na diabetes Mellitus.  Conclusão: Esta revisão permitiu determinar que a lipohipertrofia, uma complicação secundária do tratamento com insulina na diabetes Mellitus, origina-se em fatores tais como a técnica de aplicação e rotação inadequadas dos pontos de injeção, o escasso conhecimento dos pacientes sobre o tratamento e a falta de educação do pessoal sanitário com relação ao uso das técnicas de aplicação da insulina.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[hipertrofia]]></kwd>
<kwd lng="es"><![CDATA[conocimiento]]></kwd>
<kwd lng="es"><![CDATA[educación]]></kwd>
<kwd lng="es"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="es"><![CDATA[insulina]]></kwd>
<kwd lng="en"><![CDATA[hypertrophy]]></kwd>
<kwd lng="en"><![CDATA[knowledge]]></kwd>
<kwd lng="en"><![CDATA[education]]></kwd>
<kwd lng="en"><![CDATA[Mellitus diabetes]]></kwd>
<kwd lng="en"><![CDATA[insulin]]></kwd>
<kwd lng="pt"><![CDATA[hipertrofia]]></kwd>
<kwd lng="pt"><![CDATA[conhecimento]]></kwd>
<kwd lng="pt"><![CDATA[educação]]></kwd>
<kwd lng="pt"><![CDATA[diabetes mellitus]]></kwd>
<kwd lng="pt"><![CDATA[insulina]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<collab>UK Prospective Diabetes Study Group</collab>
<article-title xml:lang=""><![CDATA[Intensive blood-glucose control with sulphonylureas or insulin compared to conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>1998</year>
<volume>352</volume>
<page-range>837-53</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[De Gols]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hannet]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Partanen]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Frid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A pan-European epidemiologic study of insulin injection technique in patients with diabetes]]></article-title>
<source><![CDATA[Pract Diab Int]]></source>
<year>2002</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>71-6</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Volkova]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Davidenko]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lypohypertrophy in patients receiving insulin therapy: state of the art]]></article-title>
<source><![CDATA[Diabetes Mellitus. Diagn Manag Treat]]></source>
<year>2011</year>
<volume>2</volume>
<page-range>80-3</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wallymahmed M]]></surname>
<given-names><![CDATA[Littler P]]></given-names>
</name>
<name>
<surname><![CDATA[Clegg C.]]></surname>
<given-names><![CDATA[Haqqani M.]]></given-names>
</name>
<name>
<surname><![CDATA[Mac-Farlane]]></surname>
<given-names><![CDATA[I. A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Nodules of Fibrocollagenous Scar Tissue Induced by Subcutaneous Insulin Injections: A Cause of Poor Diabetic Control]]></article-title>
<source><![CDATA[Postgraduate Medicine Journal]]></source>
<year>2004</year>
<volume>80</volume>
<numero>950</numero>
<issue>950</issue>
<page-range>732-3</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hofman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Defining the Ideal Injection Techniques when Using 5-mm Needles in Children and Adults]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2010</year>
<volume>33</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1940-4</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dar]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Dar]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Wani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin lipohypertrophy: A non-fatal dermatological complication of diabetes mellitus reflecting poor glycemic control]]></article-title>
<source><![CDATA[Saudi Journal of Medicine and Medical Sciences]]></source>
<year>2013</year>
<volume>1</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>106-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Röcken]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Strölin]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hautkrankenheiten und Diabetes Mellitus]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Hãring]]></surname>
<given-names><![CDATA[HU]]></given-names>
</name>
<name>
<surname><![CDATA[Gallwitz]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Müller-Wieland]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Klaus-Henning]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Mehnert]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Diabetologie in Klinik und Praxis. Deutchsland]]></source>
<year>2011</year>
<page-range>524-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heinemann]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin absorption from lipodystrophic areas: a (neglected) source of trouble for insulin therapy?]]></article-title>
<source><![CDATA[J Diabetes Sci Technol]]></source>
<year>2010</year>
<volume>4</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>750-3</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Behm]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin signs in diabetes mellitus]]></article-title>
<source><![CDATA[J Eur Acad Dermatol Venereol]]></source>
<year>2012</year>
<volume>26</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1203-11</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murphy-Chutorian]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Han]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cohen]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatologic manifestations of diabetes mellitus: a review]]></article-title>
<source><![CDATA[Endocrinol Metab Clin North Am]]></source>
<year>2013</year>
<volume>42</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>869-98</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Hattem]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bootsma]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Thio]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin manifestations of diabetes]]></article-title>
<source><![CDATA[Cleve Clin J Med]]></source>
<year>2008</year>
<volume>75</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>772-776-7</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alemzadeh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Loppnow]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Parton]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kirby]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Glucose sensor evaluation of glycemic instability in pediatric type 1 diabetes mellitus]]></article-title>
<source><![CDATA[Diabetes Technol Ther]]></source>
<year>2003</year>
<volume>5</volume>
<page-range>167-73</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thow]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Marsden]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Home]]></surname>
<given-names><![CDATA[PD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Morphology of palpably abnormal injection sites and effects on absorption of isophane (NPH) insulin]]></article-title>
<source><![CDATA[Diabet Med]]></source>
<year>1990</year>
<volume>7</volume>
<page-range>795-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Hannan]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
<name>
<surname><![CDATA[Frier]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Steel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Duncan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diabetic lipohypertrophy delays insulin absorption]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>1984</year>
<volume>7</volume>
<page-range>479-80</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Griffin]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Feder]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Tamborlane]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipoatrophy associated with lispro insulin in insulin pump therapy: an old complication, a new cause?]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2001</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>174</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Del Olmo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Campos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Abellán]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Merino-Torres]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Piñón]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A case of lipoatrophy with insulin detemir]]></article-title>
<source><![CDATA[Diabetes Res Clin Pract]]></source>
<year>2008</year>
<volume>80</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>e20-1</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ampudia]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hasbum]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Carmena]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new case of li-poathrophy with lispro insulin in insulin pump therapy: is there any insulin preparation free of complications?]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2003</year>
<volume>26</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>953-4</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Radermecker]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Piérard]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Scheen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs]]></article-title>
<source><![CDATA[Am J Clin Dermatol]]></source>
<year>2007</year>
<volume>8</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perciun]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mihu]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Subcutis Ultrasound Map of Type 1 Diabetic Children Improves the Diagnosis of Local Dystrophies and Insulin Injection Technique]]></article-title>
<source><![CDATA[Pediatrics Research International Journal]]></source>
<year>2014</year>
<volume>2014</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perciun]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Aspecto ecográfico del tejido subcutáneo Distrofias como resultado de inyecciones de insulina]]></article-title>
<source><![CDATA[Médico ecografía]]></source>
<year>2010</year>
<volume>12</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>104-9</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Manjula]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Saravana]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Problems Associated with insulin administration among patients with type 2 Diabetes Mellitus]]></article-title>
<source><![CDATA[Impact Factor]]></source>
<year>2013</year>
<page-range>4.438</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Munster]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatological complications of insulin therapy in children with type 1 diabetes]]></article-title>
<source><![CDATA[European Diabetes Nursing]]></source>
<year>2014</year>
<volume>11</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>79-84</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Omar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[El-Kafoury]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[El-Araby]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors]]></article-title>
<source><![CDATA[BMC Research Notes]]></source>
<year>2011</year>
<volume>4</volume>
<page-range>290</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Annersten]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Wilman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Performing subcutaneous injections: A literature review]]></article-title>
<source><![CDATA[Wordviews on Evid Based Nurs]]></source>
<year>2005</year>
<volume>2</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>122-30</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al Ajlouni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abujbara]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Batieha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ajlouni]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of Lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[It J Endocrinol Metab]]></source>
<year>2015</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Malwa]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Balami]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Deshmukh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Groft]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bodmer]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin-induced Lipohypertrophy, past present and future: are we lose the bottle]]></article-title>
<source><![CDATA[Endocrine]]></source>
<year>2010</year>
<volume>22</volume>
<page-range>268</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hajheydari]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Kashi]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Akha]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Akbarzadeh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Frequency of lipodystrophy induced by recombinant human insulin]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2011</year>
<volume>15</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1196-201</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ji]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lou]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<source><![CDATA[Insulin pen injection technique survey in patients with type 2 diabetes in mainland China in 2010]]></source>
<year>2014</year>
<volume>30</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1087-93</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Babiker]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Datta]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipoatrophy with insulin analogues in type I diabetes]]></article-title>
<source><![CDATA[Arch Dis Child published]]></source>
<year>2010</year>
</nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeSalvo]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shanmugham]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ly]]></surname>
<given-names><![CDATA[TT]]></given-names>
</name>
<name>
<surname><![CDATA[Wilson]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Buckingham]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Accuracy evaluation of blood glucose monitoring systems in childrenon overnight closed-loop control]]></article-title>
<source><![CDATA[J Diabetes Sci Technol]]></source>
<year>2014</year>
<volume>8</volume>
<page-range>969-73</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Heinemann]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsch]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hovorka]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipohy pertrophy and the artificial pancreas: is this an issue?]]></article-title>
<source><![CDATA[J Diabetes Sci Technol]]></source>
<year>2014</year>
<volume>8</volume>
<page-range>915-7</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[DeSalvo]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of Lipohypertrophy on accuracy of continuous glucose monitoring in patients with type 1 diabetes]]></article-title>
<source><![CDATA[Diabetes Care]]></source>
<year>2015</year>
<page-range>dc151267</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cunningham]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[McKenna]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Lipohypertrophy in insulin-treated diabetes: Prevalence and associated risk factors]]></article-title>
<source><![CDATA[Journal of Diabetes Nursing]]></source>
<year>2013</year>
<volume>17</volume>
<page-range>340-3</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pettis]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intradermal Microneedle Delivery of Insulin Lispro Achieves Faster Insulin Absorption and Insulin Action than Subcutaneous Injection]]></article-title>
<source><![CDATA[Diabetes Technology &amp; Therapeutics]]></source>
<year>2011</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>435-42</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Goupta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Felner]]></surname>
<given-names><![CDATA[E.]]></given-names>
</name>
<name>
<surname><![CDATA[Prausnitz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Rapid Pharmacokinetics of Intradermal Insulin Administered Using Microneedles in Type 1 Diabetes Subjects]]></article-title>
<source><![CDATA[Diabetes Technology &amp; Therapeutics]]></source>
<year>2011</year>
<volume>13</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>451-6</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Merino]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Nuevas tecnologías en el seguimiento y control del paciente diabético Editorial De La Sociedad Española De Diabetes]]></source>
<year>2007</year>
</nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saltiel-Berzin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cypress]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gibney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Translating the research in insulin injection technique: implications for practice]]></article-title>
<source><![CDATA[Diabetes Educ]]></source>
<year>2012</year>
<volume>38</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>635-43</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lo Presti]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Ingegnosi]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Skin and subcutaneous thickness at injecting sites in children with diabetes: ultrasound findings and recommendations for giving injection]]></source>
<year>2012</year>
<volume>13</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>525-33</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Blanco]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hernández]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
<name>
<surname><![CDATA[Amaya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes]]></source>
<year>2013</year>
<volume>39</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>445-53</page-range></nlm-citation>
</ref>
<ref id="B40">
<label>40</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Grassi]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Scuntero]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Trepiccioni]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Marubbi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimizing insulin injection technique and its effect on blood glucose control]]></article-title>
<source><![CDATA[Journal of Clinical &amp; Translational Endocrinology]]></source>
<year>2014</year>
<volume>1</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>145-50</page-range></nlm-citation>
</ref>
<ref id="B41">
<label>41</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bergenstal]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<source><![CDATA[Safety and efficacy of insulin therapy delivered via a 4mm pen needle in obese patients with diabetes]]></source>
<year>2015</year>
<volume>90</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>329-38</page-range></nlm-citation>
</ref>
<ref id="B42">
<label>42</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saltiel-Berzin]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Cypress]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Gibney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Translating the research in insulin injection technique: implications for practice]]></article-title>
<source><![CDATA[Diabetes Educ]]></source>
<year>2012</year>
<volume>38</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>635-43</page-range></nlm-citation>
</ref>
<ref id="B43">
<label>43</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Al Ajlouni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abujbara]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Batieha]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ajlouni]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus]]></article-title>
<source><![CDATA[J Endocrinol Metab]]></source>
<year>2015</year>
<volume>13</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B44">
<label>44</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stanley Landau]]></surname>
<given-names><![CDATA[F.C.P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin-Induced Lipohypertrophy]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2012</year>
<volume>366</volume>
</nlm-citation>
</ref>
<ref id="B45">
<label>45</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frid]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[New injection recommendations for patients with diabetes]]></source>
<year>2010</year>
<volume>36</volume>
<numero>s2</numero>
<issue>s2</issue>
<page-range>s3-s18</page-range></nlm-citation>
</ref>
<ref id="B46">
<label>46</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gibney]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Skin and Subcutaneous Adipose Layer Thickness in Adults with Diabetes at Sites Used for Insulin Injections: Implications for Needle Length Recommendations]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Arce]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Byron]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Hirsch]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Current Medical Research &amp; Opinion]]></source>
<year>2010</year>
<volume>26</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1519-30</page-range></nlm-citation>
</ref>
<ref id="B47">
<label>47</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Selkow]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Pietrosimone]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Saliba]]></surname>
<given-names><![CDATA[S. A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Subcutaneous Thigh Fat Assessment: A Comparison of Skinfold Calipers and Ultrasound Imaging]]></article-title>
<source><![CDATA[Journal of Athletic Training]]></source>
<year>2011</year>
<volume>46</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>50-4</page-range></nlm-citation>
</ref>
<ref id="B48">
<label>48</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mokta]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Mokta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Panda]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Insulin lipodystrophy and lipohypertrophy]]></article-title>
<source><![CDATA[Indian J Endocrinol Metab]]></source>
<year>2013</year>
<volume>17</volume>
<page-range>773-4</page-range></nlm-citation>
</ref>
<ref id="B49">
<label>49</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pledger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hicks]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kirkland]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Down]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Importance of injection technique in diabetes]]></article-title>
<source><![CDATA[Journal of Diabetes Nursing]]></source>
<year>2012</year>
<volume>16</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>160</page-range></nlm-citation>
</ref>
<ref id="B50">
<label>50</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nagesh]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Kalra]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Type 1 diabetes: Syndromes in resource-challenged settings]]></article-title>
<source><![CDATA[J Pak Med Assoc]]></source>
<year>2015</year>
<volume>65</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>681-5</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
